Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  GlaxoSmithKline plc    GS7   GB0009252882

Delayed Quote. Delayed  - 08/26 05:25:56 pm
19.515 EUR   +1.59%
08/27 GLAXOSMITHKLINE : GSK’s continued commitment to innovative res..
08/25 GLAXOSMITHKLINE : GSK) Unveils Take 5 for Meningitis
08/25 INSIDE THE FDA : Frontrunners Merck & Co., Inc. (NYSE:MRK), GlaxoSm..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline plc
Develops, manufactures and distributes vaccines and other pharmaceutical products

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.

It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Managers
NameAgeSinceTitle
Andrew Witty512008Chief Executive Officer & Executive Director
Philip Hampton522015Non-Executive Chairman
Simon Dingemans522011Chief Financial Officer & Executive Director
Moncef Slaoui, PhD552006Executive Director & Chairman-Global Vaccines
Roy Malcolm Anderson682007Independent Non-Executive Director
Stacey Cartwright522011Independent Non-Executive Director
Judy Carol Lewent672011Independent Non-Executive Director
Lynn Laverty Elsenhans, MBA592012Independent Non-Executive Director
Urs Rohner572015Independent Non-Executive Director
Manvinder Singh Banga612015Senior Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 5,366,298,682 4,835,058,349 90.1% 491,505,950 9.2% 90.1%
Shareholders
NameEquities%
BlackRock Investment Management (UK) Ltd. 199,772,316 4.10%
Legal & General Investment Management Ltd. 149,809,659 3.07%
The Vanguard Group, Inc. 116,803,851 2.40%
Capital Research & Management Co. (Global Investors) 102,630,000 2.11%
Norges Bank Investment Management 92,641,000 1.90%
State Street Global Advisors Ltd. 61,837,101 1.27%
Aberdeen Asset Investments Ltd. 60,048,162 1.23%
Threadneedle Asset Management Ltd. 59,691,735 1.23%
GlaxoSmithKline Employee Trust 52,734,605 1.08%
Woodford Investment Management LLP 52,369,825 1.07%
Holdings
NameEquities%Valuation
Aspen Pharmacare Holdings Limited (APNJ) 28,234,3796.19%763,751,810 USD
Innoviva Inc (INVA) 32,005,26028.3%411,907,696 USD
Theravance Biopharma Inc (TBPH) 9,644,80720.3%246,039,027 USD
GlaxoSmithKline S.A.E. 76,161,37891.2%95,716,573 USD
Dong-A Socio Holdings Co Ltd (000640) 409,6938.46%59,982,726 USD
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSM) 555,081,92646.4%32,178,099 USD
Oncomed Pharmaceuticals Inc (OMED) 2,607,5468.61%31,629,533 USD
Allergy Therapeutics plc (AGY) 10,118,0001.72%2,535,571 USD
NeuroSearch A/S (NEUR) 1,950,5007.94%782,970 USD
Response Genetics, Inc. (RGDXQ) 5,000,00012.9%10,000 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC4.05%105 625
JOHNSON & JOHNSON15.89%325 679
ROCHE HOLDING LTD.-11.47%214 671
PFIZER INC.7.87%211 206
NOVARTIS AG-9.62%210 234
ASTRAZENECA PLC7.33%173 797
MERCK & CO., INC.18.99%173 793
GLAXOSMITHKLINE PLC20.14%105 625
SANOFI-11.77%100 075
BRISTOL-MYERS SQUIBB C..-14.57%98 196
ALLERGAN PLC-23.86%94 209
NOVO NORDISK A/S-21.38%94 102
BAYER AG-16.23%89 800
ELI LILLY AND CO-7.14%86 365
ABBOTT LABORATORIES-4.30%63 180
SHIRE PLC8.45%57 583
TEVA PHARMACEUTICAL IN..-23.10%52 759
TAKEDA PHARMACEUTICAL ..-25.18%34 830
ASTELLAS PHARMA INC-7.45%33 619
MYLAN NV-20.42%23 017
CHUGAI PHARMACEUTICAL ..-22.42%17 775
Sector Pharmaceuticals - NEC
GlaxoSmithKline plc : Connections
Alfred Escher-Stiftung
The Council for Industry & Higher Education
European Federation of Pharmaceutical Industries & Assns
Mauser Group NV
The 100 Group
National Theatre of Scotland
The Institute of International Finance, Inc.
Biotechnology Innovation Organization
International Institute for Management Development
International AIDS Vaccine Initiative, Inc.
Diversey, Inc.
PhRMA Foundation
United Way of Greater Philadelphia & Southern New Jersey
Longwood Fund Management LLC
Credit Suisse Americas Foundation
The Natural History Museum
Opernhaus Zürich AG
Institute of Medicine
Economiesuisse
French Academy of Sciences
Swiss Finance Council
Pearson Education Ltd.
Diversey Holdings, Inc.
Harvey Nichols Group Ltd.
World Presidents' Organization
Burberry Spain SA
Central Houston, Inc.
Business Council for Britain
The First Tee of Greater Houston
The University of Nottingham
Credit Suisse AG
Rockefeller Family Trust, Inc.
Zurich Chamber of Commerce
American Academy of Arts & Sciences
Institute International d'Etudes Bancaires
Massachusetts Institute of Technology
Lucerne Festival
Sunoco Chemicals, Inc.
Avenir Suisse
Sunoco Partners LLC
IMD Scholarship Foundation
Pharmaceutical Research & Manufacturers of America
Swiss Bankers Association
Indian School of Business
European Financial Services Round Table
United Kingdom Department for Business, Innovation & Skills
Glaxosmithkline Australia Pty Ltd.
Rice University
GlaxoSmithKline, Inc.
World Golf Foundation, Inc.
Indian Institute of Management
The Texas Medical Center
The Indus Entrepreneurs (Delhi)
United Way of Greater Houston
Clayton Dubilier & Rice LLP
Company contact information
980 Great West road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem